Product pipeline: Current siRNAsense project portfolio

 

  • Tissue Factor (metastasis). First indication is melanoma metastasis.
  • Secondary indications: colon cancer
  • Additional projects under evaluation
Detailed information on our product portfolio is available on pdf-format, contact:
sirnasense[at]sirnasense.com